Phathom Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
Phathom Pharmaceuticals has a total shareholder equity of $-187.1M and total debt of $518.3M, which brings its debt-to-equity ratio to -277%. Its total assets and total liabilities are $387.0M and $574.2M respectively.
Key information
-277.0%
Debt to equity ratio
US$518.31m
Debt
| Interest coverage ratio | n/a |
| Cash | US$334.68m |
| Equity | -US$187.11m |
| Total liabilities | US$574.16m |
| Total assets | US$387.04m |
Recent financial health updates
No updates
Recent updates
Following Up On Phathom Pharmaceuticals
Sep 03Phathom Pharmaceuticals: Time To Deliver Promise Of Voquezna After Frustrating Delays
Jun 26Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion
Mar 18Phathom Pharmaceuticals GAAP EPS of -$1.33 misses by $0.30
Aug 02The Prognosis For Phathom Pharmaceuticals
Jun 22Phathom Pharmaceuticals: Undiscovered Gem
Jan 20Phathom Pharma prices equity offering at $42
Dec 17Phathom Pharma launches equity offering
Dec 15Phantom Pharma completes enrollment in late-stage study of lead candidate in esophagus inflammation disorder
Nov 30Financial Position Analysis
Short Term Liabilities: PHAT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: PHAT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: PHAT has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: PHAT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PHAT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PHAT has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 29.5% each year.